Which one of the following antihypertensive medications might you use to try and prevent new-onset atrial fibrillation?
A. AtenololThe Losartan Intervention for End Point Reduction in Hypertension (LIFE) study demonstrated a relative risk reduction of 33% versus atenolol. The impact of new-onset diabetes mellitus on cardiac outcomes in the Valsartan Antihypertensive Long-Term Use Evaluation (VALUE) trial population, showed a relative risk reduction of 23% versus amlodopine.